nov 2017 hepatitis c gt3a lipid Virus-Lipid Interplay: Pathogenesis and Clinical Impact Tuning a cellular lipid kinase
Description
[DOI] [PubMed] [Google Scholar] 83.Melnikov I., Kozlov S., Saburova O., Avtaeva Y., Guria K., Gabbasov Z
DBPC, double-blind placebo-controlled trial
Adapted with permission from EASL recommendations on treatment of hepatitis C: Final update of the series by European Association for the Study of the Liver
In summary, AX demonstrates significant potential to improve muscle metabolism, optimize exercise-induced adaptations, and mitigate obesity-related dysfunction
